Clinical Trial Update: Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial exploring nivolumab with ipilimumab, with or without chemotherapy, as first-line treatment for stage IV non-small cell lung cancer; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-07-22